[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 5, Issue 2 (Int J Mol Cell Med 2016) ::
Int J Mol Cell Med 2016, 5(2): 90-99 Back to browse issues page
Gene Expression and Methylation Pattern in HRK Apoptotic Gene in Myelodysplastic Syndrome
Farhad Zaker1, Naser Amirizadeh2, Nahid Nasiri 3, Seyed Mohsen Razavi4, Ladan Teimoori-Toolabi5, Marjan Yaghmaie6, Roya Mehrasa2
1- Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
2- Blood transfusion research center, High institute for Education and Research in Transfusion Medicine, Tehran, Iran.
3- Department of Hematology, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran. , nahid.nasiri64@yahoo.com
4- Hematology and Oncology Department, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
5- Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
6- Hematology, Oncology and Stem cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:   (4943 Views)

Myelodysplastic syndromes (MDSs) are a clonal bone marrow (BM) disease characterized by ineffective hematopoiesis, dysplastic maturation and progression to acute myeloid leukemia (AML). Methylation silencing of HRK has been found in several human malignancies. In this study, we explored the association of HRK methylation status with its expression, clinical parameters and MDS subtypes in MDS patients. To study the methylation status of HRK gene, we applied Methylation Sensitive-High Resolution Melting Curve Analysis (MS-HRM) in MDS patients, as well as healthy controls and EpiTect®PCR Control DNA. Real time RT-PCR was used for gene expression analysis. Methylation frequency in promoter region of HRK in patient samples was 20.37%. Methylation of HRK was significantly related to transcriptional downregulation (P=0.023). The difference in frequency of hypermethylated HRK gene was significant between good (10%) and poor (71.42%) cytogenetic risk groups (P= 0.001), advanced stage MDS patients (66.66%) in comparison with early stage MDS patients (2.56%) (P= 0.00), higher- risk MDS group (61.53%) and lower- risk MDS group (7.31%) (P= 0.00). HRK hypermethylation was associated with advanced- stage MDS and downregulation of HRK gene may play a role in the progression of MDS.

Keywords: High Resolution Melting (HRM), methylation, myelodysplastic syndrome, HRK
Full-Text [PDF 207 kb]   (1952 Downloads)    
Type of Study: Original Article | Subject: Cancer
Received: 2016/04/9 | Accepted: 2016/06/11 | Published: 2016/06/19
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zaker F, Amirizadeh N, Nasiri N, Razavi S M, Teimoori-Toolabi L, Yaghmaie M et al . Gene Expression and Methylation Pattern in HRK Apoptotic Gene in Myelodysplastic Syndrome. Int J Mol Cell Med. 2016; 5 (2) :90-99
URL: http://ijmcmed.org/article-1-497-en.html


Volume 5, Issue 2 (Int J Mol Cell Med 2016) Back to browse issues page
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 4030